AGER and diabetes mellitus: Inhibiting RAGE with RAGE inhibitor compounds prevents RAGE-mediated signaling for the expression of inflammatory cytokines, and therefore RAGE inhibitors may prove to be clinically useful compounds for treating AD and other AGE-related diseases, including diabetes and cancer.